In conclusion, our findings indicate that CO treatment has effects on liver histopathology, improving hepatic steatosis and decreasing the activation of the apoptotic pathway, in addition to being able to restore the ultrastructure of hepatocytes in obese animals and improve SOD and AST levels. Here, SOD1 is linked to fatty liver disease.